Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Kissei Pharmaceutical Co ( (JP:4547) ) has shared an announcement.
Kissei Pharmaceutical Co., Ltd. has revised its financial forecast for the fiscal year ending March 31, 2026, reflecting an optimistic outlook with increased net sales and improved profit expectations. The company anticipates a rise in net sales by ¥4,000 million, driven by growth in both its pharmaceutical and other business sectors. Despite a projected increase in the cost of sales, operating and ordinary profits are expected to improve, with the profit attributable to owners of the parent forecasted to rise by ¥400 million, indicating a positive adjustment in financial performance.
The most recent analyst rating on (JP:4547) stock is a Hold with a Yen4473.00 price target. To see the full list of analyst forecasts on Kissei Pharmaceutical Co stock, see the JP:4547 Stock Forecast page.
More about Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and sale of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and is recognized for its contributions to healthcare through innovative drug solutions.
Average Trading Volume: 62,590
Technical Sentiment Signal: Buy
Current Market Cap: Yen164.4B
See more insights into 4547 stock on TipRanks’ Stock Analysis page.